Skip to main content

Advertisement

Log in

Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Lipopolysaccharide-binding protein (LBP) is a class 1 acute-phase protein that binds and transfers bacterial lipopolysaccharide (LPS). This study investigated the clinical value of measuring LBP for stratifying biochemical severity in acute pancreatitis by using a recently developed fully automated assay technique.

Patients and methods

We studied 71 patients with acute pancreatitis of whom 41 presented with a necrotizing course. Necrotizing pancreatitis was associated with pancreatic infections in 21 patients and with multiorgan dysfunction syndrome (MODS) in 18 patients. Serum LBP was measured for 14 days by a fully automated immunoassay and CRP was assessed on a daily routine basis.

Results

The relative quantitative systemic release of LBP was lower than that observed for CRP; however, the two parameters revealed similar dynamics, with a maximum increase in acute pancreatitis around the fourth day after onset of symptoms. As observed for CRP, LBP was significantly higher in patients who developed complications such as necrosis, pancreatic infections, single or combined MODS than in those who did not. Multiple regression analysis revealed that pulmonary failure and MODS were independent variables associated with enhanced LBP release, while the development of necrosis, pancreatic infections and MODS were the corresponding variables for increased CRP levels.

Conclusions

Systemic LBP concentrations are significantly elevated in acute pancreatitis and closely correlate with overall disease severity. However, compared with CRP, LBP does not contribute to an improved severity stratification in acute pancreatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  1. Beger HG, Bittner R, Block S, Büchler M (1986) Bacterial contamination of pancreatic necrosis. Gastroenterology 49:433–438

    Google Scholar 

  2. Isenmann R, Rau B, Beger HG (1999) Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 86:1020–1024

    Article  CAS  PubMed  Google Scholar 

  3. Tenner S, Sica G, Hughes M, Noordhoek E, Feng S, Zinner M, Banks PA (1997) Relationship of necrosis to organ failure in sever acute pancreatitis. Gastroenterology 113:899–903

    Google Scholar 

  4. Banerjee AK, Kaul A, Bache E, Doran J, Nicholson ML (1994) Multicentre audit of death from acute pancreatitis. Br J Surg 81:1541

    CAS  Google Scholar 

  5. Schulz HU, Niederau C, Klonowski-Stumpe H, Halangk W, Luthen R, Lippert H (1999) Oxidative stress in acute pancreatitis. Hepatogastroenterology 46:2736–2750

    CAS  PubMed  Google Scholar 

  6. Norman J (1998) The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 175:76–83

    CAS  PubMed  Google Scholar 

  7. Saluja AK, Steer ML (1999) Pathophysiology of acute pancreatitis. Role of cytokines and other mediators of inflammation. Digestion 60:127–133

    Article  Google Scholar 

  8. Buttenschoen K, Berger D, Hiki N, Buttenschoen DC, Vasilescu C, Chikh-Torab F, Seidelmann M, Beger HG (2000) Endotoxin and antiendotoxin antibodies in patients with acute pancreatitis. Eur J Surg 166:459–466

    Article  CAS  PubMed  Google Scholar 

  9. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, DiPadova F, et al (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8:217–225

    CAS  PubMed  Google Scholar 

  10. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ (1990) Structure and function of lipopolysaccharide binding protein. Science 249:1429–1431

    CAS  PubMed  Google Scholar 

  11. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433

    CAS  PubMed  Google Scholar 

  12. Schumann RR (1992) Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review. Res Immunol 143:11–15

    CAS  PubMed  Google Scholar 

  13. Mathison JC, Tobias PS, Wolfson E, Ulevitch RJ (1992) Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of Gram-negative LPS. J Immunol 149:200–206

    CAS  PubMed  Google Scholar 

  14. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD (1994) Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as cofactor in the neutralization of LPS. J Exp Med 180:1025–1035

    CAS  PubMed  Google Scholar 

  15. Froon A, AHM, Dentener MA, Greve JWM, Ramsay G, Buurman WA (1995) Lipopolysaccharide toxicity–regulating proteins in bacteremia. J Infect Dis 171:1250–1257

    CAS  PubMed  Google Scholar 

  16. Myc A, Buck J, Gonin J, Reynolds B, Hammerling U, Emanuel D (1997) The level of lipopolysacchride-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome. Clin Diagn Lab Immunol 4:113–116

    CAS  PubMed  Google Scholar 

  17. Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180:1584–1589

    Article  CAS  PubMed  Google Scholar 

  18. Erwin PJ, Lewis H, Dolan S, Tobias PS, Schumann RR, Lamping N, Wisdom GB, Rowlands BJ, Halliday I (2000) Lipopolysaccharide binding protein in acute pancreatitis. Crit Care Med 28:104–109

    CAS  PubMed  Google Scholar 

  19. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, Modlin I (1999) Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 25:195–210

    CAS  PubMed  Google Scholar 

  20. Buchler MW, Gloor B, Muller CA, Friess H, Seiler CA, Uhl W (2000) Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 232:619–626

    Article  CAS  PubMed  Google Scholar 

  21. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH (1995) MedCalc: a new computer program for medical statistics. Comp Methods Prog Biomed 48:257–262

    Article  CAS  Google Scholar 

  22. Runkel N (1998) Pathogenesis of pancreatogenic sepsis. Langenbecks Arch Chir Suppl Kongressbd 115:439–442

    Google Scholar 

  23. Novitsky TJ (1994) Limulus amebocyte lysate (LAL) detection of endotoxin in human blood. J Endotoxin Res 1:253–263

    CAS  Google Scholar 

  24. Rolansky PE, Novitsky TJ (1991) Sensitivity of Limulus amebocyte lysate (LAL) to LAL-reactive glucans. J Clin Microbiol 29:2477–2483

    PubMed  Google Scholar 

  25. Schumann RR, Zweiger J (1999) A novel acute-phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med 37:271–274

    CAS  PubMed  Google Scholar 

  26. Oberhoffer M, Karzai W, Meier-Hellmann A, Reinhardt K (1998) Procalcitonin. Ein neuer diagnostischer Parameter bei schweren Infektionen und Sepsis. Anaesthesist 47:581–587

    CAS  PubMed  Google Scholar 

  27. Russwurm S, Oberhoffer M, Zipfel PF, Reinhardt K (1999) Procalcitonin-a novel biochemical marker for the mediator directed therapy of sepsis. Mol Med Today 5:286–287

    Article  CAS  PubMed  Google Scholar 

  28. Rau B, Steinbach G, Gansauge F, Mayer JM, Grünert A, Beger HG (1997) The potential role of procalcitonin and interleukin-8 in the prediction of infected necrosis in acute pancreatitis. Gut 41:832–840

    CAS  PubMed  Google Scholar 

  29. Rau B, Steinbach G, Baumgart K, Gansauge F, Grünert A, Beger HG (2000) Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit Care Med 28:736–742

    CAS  PubMed  Google Scholar 

  30. Uhl W, Büchler M, Malfertheiner P, Martini M, Beger HG (1991) PMN-Elastase in comparison with CRP, antiproteases and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 6:253–259

    CAS  PubMed  Google Scholar 

  31. Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, Beger HG, Hietaranta AJ, Puolakkainen PA (2000) Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 355:1955–1960

    Article  CAS  PubMed  Google Scholar 

  32. Mayer J, Rau B, Grewe M, Schoenberg MH, Nevalainen T, Beger HG (1998) Secretory Phospholipase A2 in patients with infected pancreatic necroses in acute pancreatitis. Pancreas 17:272–277

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank DPC Biermann, Bad Nauheim, Germany for their support by kindly providing the LBP kits.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bettina Rau.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rau, B., Steinbach, G., Krüger, C.M. et al. Clinical value of lipopolysaccharide-binding protein (LBP) determinations in acute pancreatitis. Langenbecks Arch Surg 388, 181–188 (2003). https://doi.org/10.1007/s00423-003-0390-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-003-0390-6

Keywords

Navigation